Tät III –Pelvic Floor Exercises for men 1.2 Apk

Tät®III is intended to support men with pelvic floor exercises in cases where these kinds of exercises have been recommended by medical staff. Urine leakage upon coughing, jumping or sneezing – stress incontinence – is common after an operation for prostate cancer (radical prostatectomy). It is recommended that pelvic floor exercises start before the operation is performed, and that the exercises continue after the operation.

The Tät®III app provides a pelvic floor muscle training programme in six basic and six advanced levels, with increasing severity. Four different kinds of “contractions” are described. The app includes visual aids for each level of training, a statistics function and the ability to create reminders. The app also includes information about the pelvic floor, prostate cancer operations and urinary incontinence. There is information about factors that affect incontinence.

Studies have shown that urine leakage problems can decrease more rapidly with the help of pelvic floor exercises. The Tät®III app has been shown to facilitate these exercises. The Tät®III app builds upon the Tät® for women, which has been evaluated in several studies with positive results for the treatment of stress urinary incontinence, see www.econtinence.se

In order to follow the use, there are questions integrated into the app regarding age, gender, education, residence (urban or rural), prostate operations, and urinary leakage. After one month there are follow-up questions regarding urinary leakage and exercises and it is possible to comment about the app. Three months after download follow-up questions regarding urinary leakage, exercises and the app are repeated. Answering the questionnaires is voluntary, and entered data is anonymously transferred to the research database. The answers cannot be traced to a specific user or telephone number. The Ethics Review Board in Umeå has issued an advisory opinion, stating that they do not see any ethical problem with this study.

The Tät®III app is CE-marked as a Class I medical device according to the EU regulation 2017/745 MDR.

©Tät.nu 2010-2020, Tät®2020, Umeå, Sweden